Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 36 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 33 34 35 36 presentations: 1 to 50 of 1788
WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES
UPDATE ON HIV VIROLOGY   (ABSTRACT 2001)
Paul Bieniasz
The Rockefeller University, New York, NY, USA
from CROI 2019 on March 4, 2019 9:00 AM-12:25 PM
WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES
UPDATE ON HIV IMMUNOLOGY   (ABSTRACT 2002)
Penelope L. Moore
University of Witwatersrand, Johannesburg, South Africa
from CROI 2019 on March 4, 2019 9:00 AM-12:25 PM
WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES
UPDATE ON HIV PREVENTION   (ABSTRACT 2003)
Sharon L. Hillier
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2019 on March 4, 2019 9:00 AM-12:25 PM
WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES
UPDATE ON TUBERCULOSIS TREATMENT AND PREVENTION   (ABSTRACT 2004)
Constance A. Benson
University of California San Diego, San Diego, CA, USA
from CROI 2019 on March 4, 2019 9:00 AM-12:25 PM
WORKSHOP: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES
UPDATE ON HIV CURE   (ABSTRACT 2005)
Katharine J Bar
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2019 on March 4, 2019 9:00 AM-12:25 PM
WORKSHOP: MARTIN DELANEY PRESENTATION
DISCOVERING THE ART IN SCIENCE (AND MEDICINE): THE HUMAN CONNECTION   (ABSTRACT 2)
Dawn Averitt
The Well Project, Women's Research Initiative on HIV/AIDS, South Strafford, VT, USA
from CROI 2019 on March 4, 2019 12:25 PM-1:40 PM
WORKSHOP: CLINICAL TRIAL DESIGN AND ANALYSIS
FELLOW TRAVELERS: INTERPRETING THE IMPACT OF THE MICROBIOME IN CLINICAL INTERVENTION   (ABSTRACT 6)
Adam Burgener
Public Health Agency of Canada, Winnipeg, Canada
from CROI 2019 on March 4, 2019 2:00 PM-4:00 PM
WORKSHOP: CLINICAL TRIAL DESIGN AND ANALYSIS
MISSING U: HANDLING AND AVOIDING MISSING DATA IN CLINICAL TRIALS   (ABSTRACT 7)
Heather Ribaudo
Harvard School of Public Health, Boston, MA, USA
from CROI 2019 on March 4, 2019 2:00 PM-4:00 PM
WORKSHOP: CLINICAL TRIAL DESIGN AND ANALYSIS
DESIGNING & INTERPRETING HIV PREVENTION TRIALS IN THE ERA OF EFFECTIVE INTERVENTIONS   (ABSTRACT 8)
David Dunn
University College London, London, United Kingdom
from CROI 2019 on March 4, 2019 2:00 PM-4:00 PM
WORKSHOP: FRONTIERS IN LABORATORY SCIENCE
ENGINEERING THE LATENT RESERVOIR   (ABSTRACT 3)
Paula Cannon
University of Southern California, Los Angeles, CA, USA
from CROI 2019 on March 4, 2019 2:00 PM-4:00 PM
WORKSHOP: FRONTIERS IN LABORATORY SCIENCE
MORE COLORFUL IMMUNOLOGY: TARGETED ISOLATION OF MONOCLONAL ANTIBODIES   (ABSTRACT 5)
Rosemarie Diana Mason
NIAID, NIH, Bethesda, MD, USA
from CROI 2019 on March 4, 2019 2:00 PM-4:00 PM
WORKSHOP: FRONTIERS IN LABORATORY SCIENCE
NOVEL IMAGING APPROACHES TO CHARACTERIZE AND QUANTIFY VIRAL RESERVOIRS   (ABSTRACT 4)
Jacob D Estes
Oregon Health and Sciences University, Beaverton, OR, USA
from CROI 2019 on March 4, 2019 2:00 PM-4:00 PM
WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP ON HEPATITIS
HEPATITIS E: CLINICAL CHALLENGES   (ABSTRACT 2006)
Sven Pischke
University Hospital Hamburg–Eppendorf, Hamburg, Germany
from CROI 2019 on March 4, 2019 2:00 PM-4:00 PM
WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP ON HEPATITIS
HEPATITIS D: CLINICAL CHALLENGES   (ABSTRACT 2007)
Jeffrey S. Glenn
Stanford University, Stanford, CA, USA
from CROI 2019 on March 4, 2019 2:00 PM-4:00 PM
WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP ON HEPATITIS
NASH IN HIV   (ABSTRACT 2008)
Giada Sebastiani
Chronic Viral Illness Service and Research Institute of McGill University Health Centre, Montreal, Canada
from CROI 2019 on March 4, 2019 2:00 PM-4:00 PM
WORKSHOP: INTERACTIVE CASE-BASED WORKSHOP ON HEPATITIS
RETREATMENT OF HCV IN ADVANCED LIVER DISEASE   (ABSTRACT 2009)
John D Scott
University of Washington, Seattle, WA, USA
from CROI 2019 on March 4, 2019 2:00 PM-4:00 PM
OPENING SESSION
SESSION HOST
Richard A. Koup
VRC, NIAID, NIH, Bethesda, MD, USA
from CROI 2019 on March 4, 2019 5:00 PM-7:00 PM
OPENING SESSION
ENDING THE HIV EPIDEMIC: A PLAN FOR THE UNITED STATES   (ABSTRACT 2010)
Anthony S Fauci
NIH, Bethesda, MD, USA
from CROI 2019 on March 4, 2019 5:00 PM-7:00 PM
OPENING SESSION
BERNARD FIELDS LECTURE: DISCOVERY AND DEVELOPMENT OF HIV BROADLY NEUTRALIZING ANTIBODIES   (ABSTRACT 10)
Michel Nussenzweig
Rockefeller University, New York, NY, USA
from CROI 2019 on March 4, 2019 5:00 PM-7:00 PM
OPENING SESSION
N'GALY-MANN LECTURE: THAILAND'S ACHIEVEMENTS IN HIV TREATMENT, PREVENTION, AND CURE RESEARCH   (ABSTRACT 11)
Praphan Phanuphak
Thai Red Cross AIDS Research Centre, Bangkok, Thailand
from CROI 2019 on March 4, 2019 5:00 PM-7:00 PM
TUESDAY PLENARY SESSION
DENIAL, DOOM, OR DESTINY? RESURGENT STIS IN HIV CARE AND PREVENTION   (ABSTRACT 12)
Jeanne M Marrazzo
University of Alabama, Birmingham, USA
from CROI 2019 on March 5, 2019 8:30 AM-9:30 AM
TUESDAY PLENARY SESSION
INFLAMMATION: TAMING THE FLAMES   (ABSTRACT 13)
Irini Sereti
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2019 on March 5, 2019 8:30 AM-9:30 AM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
HPV VACCINE WITH LEEP DID NOT PREVENT RECURRENT CERVICAL HSIL IN HIV-INFECTED WOMEN   (ABSTRACT 14)
Cindy Firnhaber
University of Colorado Medical Center, Aurora, CO, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
OPTIMAL LUNG CANCER SCREENING CRITERIA AMONG PERSONS LIVING WITH HIV   (ABSTRACT 15)
Subhashini A Sellers
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
HIV IS ASSOCIATED WITH DECREASED BREAST CANCER SURVIVAL: A PROSPECTIVE COHORT STUDY   (ABSTRACT 16)
Katrin Sara Sadigh
Brigham and Women's Hospital, Boston, MA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
LONG-TERM OUTCOMES OF 58 PATIENTS WITH HIV AND KSHV+ MULTICENTRIC CASTLEMAN DISEASE   (ABSTRACT 17)
Ramya Ramaswami
HIV AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
REDUCTION OF KAPOSI SARCOMA–ASSOCIATED HERPESVIRUS LATENCY USING CRISPR-CAS9   (ABSTRACT 18)
For Yue Tso
University of Nebraska - Lincoln, Lincoln, NE, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
THE ROLE OF WILMS' TUMOR 1 IN KAPOSI SARCOMA HERPESVIRUS ONCOGENESIS   (ABSTRACT 19)
Ayana Morales
Weill Cornell Medical College, New York, NY, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
QUANTIFICATION OF KSHV DNA AS A DIAGNOSTIC TEST FOR KAPOSI SARCOMA IN AFRICA   (ABSTRACT 20)
Aggrey Semeere
Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
TWO NOVEL POTENTIAL THERAPEUTIC TARGETS IN THE KSHV LIFE CYCLE   (ABSTRACT 21)
Thomas Schulz
Medizinischen Hochschule Hannover, Hannover, Germany
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
RANDOMIZED TRIAL OF RALTEGRAVIR-ART VS EFAVIRENZ-ART WHEN INITIATED DURING PREGNANCY   (ABSTRACT 39)
Mark Mirochnick
Boston University School of Medicine, Hingham, MA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
RCT OF DOLUTEGRAVIR VS EFAVIRENZ-BASED THERAPY INITIATED IN LATE PREGNANCY: DOLPHIN-2   (ABSTRACT 40)
Saye Khoo
University of Liverpool Institute of Translational Medicine, Liverpool, United Kingdom
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
MATERNAL HBV VIREMIA IS ASSOCIATED WITH ADVERSE INFANT OUTCOMES IN HIV/HBV WOMEN   (ABSTRACT 41)
Debika Bhattacharya
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
IMPACT OF IMPROVED NUTRITION/SANITATION ON NEURODEVELOPMENT OF HIV-EXPOSED CHILDREN   (ABSTRACT 42)
Robert Ntozini
Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
UNIQUE IMMUNOLOGICAL AND VIROLOGICAL FEATURES OF EARLY TREATED HIV-INFECTED NEWBORNS   (ABSTRACT 43)
Pilar Garcia Broncano
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
NEONATAL ART < 7 DAYS VS 7-28 DAYS REDUCED TIME TO SUPPRESSION   (ABSTRACT 44)
Sara Dominguez Rodriguez
Fundación Investigación Biomédica Hospital 12 Octubre, Madrid, Spain
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
SAFETY AND PHARMACOKINETICS OF MONOCLONAL ANTIBODY, VRC01LS, IN HIV-EXPOSED NEWBORNS   (ABSTRACT 45)
Elizabeth J McFarland
University of Colorado School of Medicine, Aurora, CO, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
BICTEGRAVIR/FTC/TAF SINGLE-TABLET REGIMEN IN ADOLESCENTS & CHILDREN: WEEK 48 RESULTS   (ABSTRACT 46)
Aditya Gaur
St. Jude Children's Research Hospital, Memphis, TN, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
BREAKING BONES IS BAD: INCIDENT FRACTURE AND MORTALITY IN THE HIV OUTPATIENT STUDY   (ABSTRACT 30)
Linda Ann Battalora
Colorado School of Mines, Golden, CO, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
COPD AND THE RISK FOR MYOCARDIAL INFARCTION BY TYPE IN PEOPLE LIVING WITH HIV   (ABSTRACT 31)
Kristina Crothers
University of Washington, Seattle, WA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
SUDDEN CARDIAC DEATH AMONG HIV-INFECTED AND -UNINFECTED VETERANS   (ABSTRACT 32)
Matthew Freiberg
Vanderbilt University School of Medicine, Nashville, TN, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
HIV POST SCD STUDY: 80% HIGHER RATE OF AUTOPSY-DEFINED SUDDEN ARRHYTHMIC DEATH IN HIV   (ABSTRACT 33)
Zian H. Tseng
UCSF, San Francisco, CA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
CABOTEGRAVIR IS NOT ASSOCIATED WITH WEIGHT GAIN IN HIV-NEGATIVE INDIVIDUALS: HPTN 077   (ABSTRACT 34)
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
ASSESSING THE PROBIOTIC EFFECT IN TREATED HIV: RESULTS OF ACTG A5350   (ABSTRACT 35)
Edgar Turner Overton
University of Alabama, Birmingham, AL, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
FACTOR X INHIBITION REDUCES COAGULATION BUT NOT INFLAMMATION IN PERSONS WITH HIV   (ABSTRACT 36)
Jason V Baker
Hennepin Healthcare Research Institute (U of MN), Minneapolis, MN, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
SAFETY, TOLERABILITY AND IMMUNOLOGIC ACTIVITY OF RUXOLITINIB ADDED TO SUPPRESSIVE ART   (ABSTRACT 37)
Vincent C. Marconi
School of Medicine, Emory University, Atlanta, GA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
INCIDENT SYPHILIS RATES AND PREDICTORS IN US WOMEN WITH HIV, 2005-2016   (ABSTRACT 47)
Jodie Dionne-Odom
University of Alabama at Birmingham, Birmingham, AL, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
PREPARING FOR PREP IN ENGLAND: PREVALENCE AND INCIDENCE OF HIV AND BACTERIAL STIS   (ABSTRACT 48)
Dana Ogaz
Public Health England, London, United Kingdom
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
EXPANDING TESTING STRATEGIES IN PARIS: A FREE POSTAL COMPREHENSIVE STI TEST KIT   (ABSTRACT 49)
Heloise M Delagreverie
Hôpital Saint Louis - APHP, Paris, France
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
RANDOMIZED CONTROLLED TRIAL OF INTRAUTERINE DEVICE SAFETY IN WOMEN LIVING WITH HIV   (ABSTRACT 50)
Catherine S Todd
FHI360, Durham, NC, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
<< first | < prev page: of 36 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 33 34 35 36 presentations: 1 to 50 of 1788